Wave Life Sciences Ltd.
Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $2.84
- 52-Week Range
- $2.75 – $21.73
- Market Cap
- $546.32M
- P/E (TTM)
- —
- EPS (TTM)
- -1.07
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.36
- PEG Ratio
- —
- Return on Equity
- -78.80%
- Return on Assets
- -37.97%
- Gross Margin
- -189.60%
- Operating Margin
- -320.94%
- Profit Margin
- -296.86%
- Current Ratio
- 8.38
- Debt/Equity
- 0.11
- Total Debt
- $43.27M
- Free Cash Flow
- $-132.66M
- Revenue Growth
- 73.00%
- Earnings Growth
- —
- Enterprise Value
- $158.85M
Market Snapshot
About
Wave Life Sciences Ltd. is a clinical-stage genetic medicines company. The company develops stereopure oligonucleotide therapies targeting genetic diseases affecting the central nervous system, liver, and other organs.